TEL AVIV, Israel and WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology ...
The only gene-editing therapy approved for beta-thalassaemia at present is Vertex Pharma's CRISPR-based Casgevy ...
The FDA granted accelerated approval to Kresladi for the treatment of pediatric patients with severe LAD-I due to biallelic variants in ITGB2 without an available HLA-matched sibling donor for ...
The eli-cel drug product was manufactured by transduction of autologous enriched CD34+ hematopoietic progenitor cells with Lenti-D lentiviral vector encoding the ABCD1 cDNA under the control of an ...
Cystinosis is a multisystemic lysosomal storage disorder caused by pathogenic variants in CTNS, the gene encoding cystinosin, a lysosomal transmembrane cystine transporter. In patients with cystinosis ...
Consistent Trophoblast Cell Surface Antigen 2 Positivity in Tracheobronchial Adenoid Cystic Carcinoma: Expanding Antibody-Drug Conjugate Opportunities in Rare Thoracic Tumor We sought to evaluate PBSC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results